Applied Spectral Imaging (ASI) | a ZYTOMICS company

Applied Spectral Imaging (ASI) is a multinational biomedical company founded in 1993. It specializes in developing and manufacturing advanced microscopy imaging and digital analysis tools for biomedical applications, particularly in pathology and cytogenetics. With over 5,000 systems installed in more than 80 countries, ASI is recognized as a leader in biomedical imaging technology. The company offers a diverse range of solutions powered by its proprietary GenASIs technology, which supports various imaging modalities, including brightfield, fluorescence, and spectral imaging. ASI's product lineup includes tools for karyotyping, fluorescence in situ hybridization (FISH), digital pathology, and immunohistochemistry (IHC). Its products are FDA-cleared and IVDR-compliant, ensuring they meet regulatory standards for clinical diagnostics. ASI serves hospitals, service laboratories, and research centers, focusing on improving diagnostic accuracy and efficiency through automation and computer-aided workflows. With offices in the USA and Asia, ASI has a robust global distribution network, emphasizing long-term customer relationships and a commitment to quality in every diagnosis.

• Employees 83
• Founded 1993
• Annual Revenue $4803000